カテゴリ： 世界, 医療/バイオ, QYResearch

子宮内膜症治療薬の世界市場2023年：ホルモン避妊薬、プロゲステロン補充療法、GnRHAアナログ

■ 英語タイトル：Global Endometriosis Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7461）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7461
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：94
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[子宮内膜症治療薬の世界市場2023年：ホルモン避妊薬、プロゲステロン補充療法、GnRHAアナログ]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料は子宮内膜症治療薬のグローバル市場について調査・分析し、世界の子宮内膜症治療薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ホルモン避妊薬、プロゲステロン補充療法、GnRHAアナログ）、用途別セグメント分析（病院、薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Bayer、Abbott、Ferring、Xianju Pharma、AstraZeneca、Merck & Co、Takeda Pharmaceutical、Theramex、Livzon Pharmaceutical Group、Beijing Biote Pharmaceutical Co., ltdなどが含まれています。子宮内膜症治療薬のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、子宮内膜症治療薬市場規模を算出する際に考慮しました。

・子宮内膜症治療薬市場の概要
- 子宮内膜症治療薬の種類別セグメント
- 世界の子宮内膜症治療薬市場規模：タイプ別分析（ホルモン避妊薬、プロゲステロン補充療法、GnRHAアナログ）
- 子宮内膜症治療薬の用途別セグメント
- 世界の子宮内膜症治療薬市場規模：用途別分析（病院、薬局、その他）
- 世界の子宮内膜症治療薬市場規模予測（2018年-2029年）

・子宮内膜症治療薬市場の成長トレンド
- 子宮内膜症治療薬の地域別市場規模（2018年-2029年）
- 子宮内膜症治療薬市場ダイナミクス
- 子宮内膜症治療薬の業界動向
- 子宮内膜症治療薬市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：ホルモン避妊薬、プロゲステロン補充療法、GnRHAアナログ
- 世界の子宮内膜症治療薬のタイプ別市場規模（2018年-2023年）
- 世界の子宮内膜症治療薬のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、薬局、その他
- 世界の子宮内膜症治療薬の用途別市場規模（2018年-2023年）
- 世界の子宮内膜症治療薬の用途別市場規模（2024年-2029年）

・子宮内膜症治療薬の地域別市場規模
- 北米の子宮内膜症治療薬市場規模（2018年-2029年）
- 米国の子宮内膜症治療薬市場規模（2018年-2029年）
- ヨーロッパの子宮内膜症治療薬市場規模（2018年-2029年）
- アジア太平洋の子宮内膜症治療薬市場規模（2018年-2029年）
- 中国の子宮内膜症治療薬市場規模（2018年-2029年）
- 日本の子宮内膜症治療薬市場規模（2018年-2029年）
- 韓国の子宮内膜症治療薬市場規模（2018年-2029年）
- インドの子宮内膜症治療薬市場規模（2018年-2029年）
- オーストラリアの子宮内膜症治療薬市場規模（2018年-2029年）
- 中南米の子宮内膜症治療薬市場規模（2018年-2029年）
- 中東・アフリカの子宮内膜症治療薬市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Bayer、Abbott、Ferring、Xianju Pharma、AstraZeneca、Merck & Co、Takeda Pharmaceutical、Theramex、Livzon Pharmaceutical Group、Beijing Biote Pharmaceutical Co., ltd

・アナリストの観点/結論

・調査手法と情報源

Endometriosis (EMs) is a common gynecological disease in women caused by the implantation of endometrial cells in abnormal locations. Endometrial cells should grow in the uterine cavity, but because the uterine cavity through the fallopian tube and ovary, pelvic cavity is connected, so the endometrial cells can enter the ovary, pelvic cavity and uterus adjacent area through the fallopian tube ectopic growth. It is one of the most common gynecological diseases, but also a relatively common clinical benign disease in women of childbearing age, the disease affects 10% of women of childbearing age, in recent years shows a significant upward trend, the disease is characterized by dysmenorrhea, pelvic pain and infertility, seriously affecting women’s reproductive health and quality of life.
Highlights
The global Endometriosis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In China markets, the core manufacturers of endometriosis treatment includes Bayer, Abbott, Ferring etc and the top 5 companies hold a share over 65%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Endometriosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endometriosis Treatment.
The Endometriosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Endometriosis Treatment market comprehensively. Regional market sizes, concerning products by type, by distribution channel, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endometriosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by distribution channel, and by regions.
By Company
Bayer
Abbott
Ferring
Xianju Pharma
AstraZeneca
Merck & Co
Takeda Pharmaceutical
Theramex
Livzon Pharmaceutical Group
Beijing Biote Pharmaceutical Co., ltd
Segment by Type
Hormonal Contraceptives
Progesterone Replacement Therapy
GnRHAnalogue
Segment by Distribution Channel
Hospital
Retail Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, distribution channel, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endometriosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by distribution channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endometriosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Hormonal Contraceptives
1.2.3 Progesterone Replacement Therapy
1.2.4 GnRHAnalogue
1.3 Market by Distribution Channel
1.3.1 Global Endometriosis Treatment Market Growth by Distribution Channel: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endometriosis Treatment Market Perspective (2018-2029)
2.2 Endometriosis Treatment Growth Trends by Region
2.2.1 Global Endometriosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Endometriosis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Endometriosis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Endometriosis Treatment Market Dynamics
2.3.1 Endometriosis Treatment Industry Trends
2.3.2 Endometriosis Treatment Market Drivers
2.3.3 Endometriosis Treatment Market Challenges
2.3.4 Endometriosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endometriosis Treatment Players by Revenue
3.1.1 Global Top Endometriosis Treatment Players by Revenue (2018-2023)
3.1.2 Global Endometriosis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Endometriosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endometriosis Treatment Revenue
3.4 Global Endometriosis Treatment Market Concentration Ratio
3.4.1 Global Endometriosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endometriosis Treatment Revenue in 2022
3.5 Endometriosis Treatment Key Players Head office and Area Served
3.6 Key Players Endometriosis Treatment Product Solution and Service
3.7 Date of Enter into Endometriosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endometriosis Treatment Breakdown Data by Type
4.1 Global Endometriosis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Endometriosis Treatment Forecasted Market Size by Type (2024-2029)
5 Endometriosis Treatment Breakdown Data by Distribution Channel
5.1 Global Endometriosis Treatment Historic Market Size by Distribution Channel (2018-2023)
5.2 Global Endometriosis Treatment Forecasted Market Size by Distribution Channel (2024-2029)
6 North America
6.1 North America Endometriosis Treatment Market Size (2018-2029)
6.2 North America Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Endometriosis Treatment Market Size by Country (2018-2023)
6.4 North America Endometriosis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endometriosis Treatment Market Size (2018-2029)
7.2 Europe Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Endometriosis Treatment Market Size by Country (2018-2023)
7.4 Europe Endometriosis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endometriosis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Endometriosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Endometriosis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Endometriosis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endometriosis Treatment Market Size (2018-2029)
9.2 Latin America Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Endometriosis Treatment Market Size by Country (2018-2023)
9.4 Latin America Endometriosis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endometriosis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Endometriosis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Endometriosis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Endometriosis Treatment Introduction
11.1.4 Bayer Revenue in Endometriosis Treatment Business (2018-2023)
11.1.5 Bayer Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Endometriosis Treatment Introduction
11.2.4 Abbott Revenue in Endometriosis Treatment Business (2018-2023)
11.2.5 Abbott Recent Development
11.3 Ferring
11.3.1 Ferring Company Detail
11.3.2 Ferring Business Overview
11.3.3 Ferring Endometriosis Treatment Introduction
11.3.4 Ferring Revenue in Endometriosis Treatment Business (2018-2023)
11.3.5 Ferring Recent Development
11.4 Xianju Pharma
11.4.1 Xianju Pharma Company Detail
11.4.2 Xianju Pharma Business Overview
11.4.3 Xianju Pharma Endometriosis Treatment Introduction
11.4.4 Xianju Pharma Revenue in Endometriosis Treatment Business (2018-2023)
11.4.5 Xianju Pharma Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Endometriosis Treatment Introduction
11.5.4 AstraZeneca Revenue in Endometriosis Treatment Business (2018-2023)
11.5.5 AstraZeneca Recent Development
11.6 Merck & Co
11.6.1 Merck & Co Company Detail
11.6.2 Merck & Co Business Overview
11.6.3 Merck & Co Endometriosis Treatment Introduction
11.6.4 Merck & Co Revenue in Endometriosis Treatment Business (2018-2023)
11.6.5 Merck & Co Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Detail
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Endometriosis Treatment Introduction
11.7.4 Takeda Pharmaceutical Revenue in Endometriosis Treatment Business (2018-2023)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Theramex
11.8.1 Theramex Company Detail
11.8.2 Theramex Business Overview
11.8.3 Theramex Endometriosis Treatment Introduction
11.8.4 Theramex Revenue in Endometriosis Treatment Business (2018-2023)
11.8.5 Theramex Recent Development
11.9 Livzon Pharmaceutical Group
11.9.1 Livzon Pharmaceutical Group Company Detail
11.9.2 Livzon Pharmaceutical Group Business Overview
11.9.3 Livzon Pharmaceutical Group Endometriosis Treatment Introduction
11.9.4 Livzon Pharmaceutical Group Revenue in Endometriosis Treatment Business (2018-2023)
11.9.5 Livzon Pharmaceutical Group Recent Development
11.10 Beijing Biote Pharmaceutical Co., ltd
11.10.1 Beijing Biote Pharmaceutical Co., ltd Company Detail
11.10.2 Beijing Biote Pharmaceutical Co., ltd Business Overview
11.10.3 Beijing Biote Pharmaceutical Co., ltd Endometriosis Treatment Introduction
11.10.4 Beijing Biote Pharmaceutical Co., ltd Revenue in Endometriosis Treatment Business (2018-2023)
11.10.5 Beijing Biote Pharmaceutical Co., ltd Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Endometriosis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Hormonal Contraceptives
Table 3. Key Players of Progesterone Replacement Therapy
Table 4. Key Players of GnRHAnalogue
Table 5. Global Endometriosis Treatment Market Size Growth by Distribution Channel (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Endometriosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Endometriosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Endometriosis Treatment Market Share by Region (2018-2023)
Table 9. Global Endometriosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Endometriosis Treatment Market Share by Region (2024-2029)
Table 11. Endometriosis Treatment Market Trends
Table 12. Endometriosis Treatment Market Drivers
Table 13. Endometriosis Treatment Market Challenges
Table 14. Endometriosis Treatment Market Restraints
Table 15. Global Endometriosis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Endometriosis Treatment Market Share by Players (2018-2023)
Table 17. Global Top Endometriosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Treatment as of 2022)
Table 18. Ranking of Global Top Endometriosis Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Endometriosis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Endometriosis Treatment Product Solution and Service
Table 22. Date of Enter into Endometriosis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Endometriosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Endometriosis Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Endometriosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Endometriosis Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Endometriosis Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 29. Global Endometriosis Treatment Revenue Market Share by Distribution Channel (2018-2023)
Table 30. Global Endometriosis Treatment Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 31. Global Endometriosis Treatment Revenue Market Share by Distribution Channel (2024-2029)
Table 32. North America Endometriosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Endometriosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Endometriosis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Endometriosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Endometriosis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Endometriosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Endometriosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Bayer Company Detail
Table 48. Bayer Business Overview
Table 49. Bayer Endometriosis Treatment Product
Table 50. Bayer Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 51. Bayer Recent Development
Table 52. Abbott Company Detail
Table 53. Abbott Business Overview
Table 54. Abbott Endometriosis Treatment Product
Table 55. Abbott Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 56. Abbott Recent Development
Table 57. Ferring Company Detail
Table 58. Ferring Business Overview
Table 59. Ferring Endometriosis Treatment Product
Table 60. Ferring Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 61. Ferring Recent Development
Table 62. Xianju Pharma Company Detail
Table 63. Xianju Pharma Business Overview
Table 64. Xianju Pharma Endometriosis Treatment Product
Table 65. Xianju Pharma Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 66. Xianju Pharma Recent Development
Table 67. AstraZeneca Company Detail
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Endometriosis Treatment Product
Table 70. AstraZeneca Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Merck & Co Company Detail
Table 73. Merck & Co Business Overview
Table 74. Merck & Co Endometriosis Treatment Product
Table 75. Merck & Co Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 76. Merck & Co Recent Development
Table 77. Takeda Pharmaceutical Company Detail
Table 78. Takeda Pharmaceutical Business Overview
Table 79. Takeda Pharmaceutical Endometriosis Treatment Product
Table 80. Takeda Pharmaceutical Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 81. Takeda Pharmaceutical Recent Development
Table 82. Theramex Company Detail
Table 83. Theramex Business Overview
Table 84. Theramex Endometriosis Treatment Product
Table 85. Theramex Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 86. Theramex Recent Development
Table 87. Livzon Pharmaceutical Group Company Detail
Table 88. Livzon Pharmaceutical Group Business Overview
Table 89. Livzon Pharmaceutical Group Endometriosis Treatment Product
Table 90. Livzon Pharmaceutical Group Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 91. Livzon Pharmaceutical Group Recent Development
Table 92. Beijing Biote Pharmaceutical Co., ltd Company Detail
Table 93. Beijing Biote Pharmaceutical Co., ltd Business Overview
Table 94. Beijing Biote Pharmaceutical Co., ltd Endometriosis Treatment Product
Table 95. Beijing Biote Pharmaceutical Co., ltd Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 96. Beijing Biote Pharmaceutical Co., ltd Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometriosis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Endometriosis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Hormonal Contraceptives Features
Figure 4. Progesterone Replacement Therapy Features
Figure 5. GnRHAnalogue Features
Figure 6. Global Endometriosis Treatment Market Size Comparison by Distribution Channel (2023-2029) & (US$ Million)
Figure 7. Global Endometriosis Treatment Market Share by Distribution Channel: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Others Case Studies
Figure 11. Endometriosis Treatment Report Years Considered
Figure 12. Global Endometriosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Endometriosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Endometriosis Treatment Market Share by Region: 2022 VS 2029
Figure 15. Global Endometriosis Treatment Market Share by Players in 2022
Figure 16. Global Top Endometriosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Endometriosis Treatment Revenue in 2022
Figure 18. North America Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Endometriosis Treatment Market Share by Country (2018-2029)
Figure 20. United States Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Endometriosis Treatment Market Share by Country (2018-2029)
Figure 24. Germany Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Endometriosis Treatment Market Share by Region (2018-2029)
Figure 32. China Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Endometriosis Treatment Market Share by Country (2018-2029)
Figure 40. Mexico Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Endometriosis Treatment Market Share by Country (2018-2029)
Figure 44. Turkey Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Endometriosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Bayer Revenue Growth Rate in Endometriosis Treatment Business (2018-2023)
Figure 47. Abbott Revenue Growth Rate in Endometriosis Treatment Business (2018-2023)
Figure 48. Ferring Revenue Growth Rate in Endometriosis Treatment Business (2018-2023)
Figure 49. Xianju Pharma Revenue Growth Rate in Endometriosis Treatment Business (2018-2023)
Figure 50. AstraZeneca Revenue Growth Rate in Endometriosis Treatment Business (2018-2023)
Figure 51. Merck & Co Revenue Growth Rate in Endometriosis Treatment Business (2018-2023)
Figure 52. Takeda Pharmaceutical Revenue Growth Rate in Endometriosis Treatment Business (2018-2023)
Figure 53. Theramex Revenue Growth Rate in Endometriosis Treatment Business (2018-2023)
Figure 54. Livzon Pharmaceutical Group Revenue Growth Rate in Endometriosis Treatment Business (2018-2023)
Figure 55. Beijing Biote Pharmaceutical Co., ltd Revenue Growth Rate in Endometriosis Treatment Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 毛細血管拡張性運動失調症（AT）治療の世界市場2023年：内服錠、注射剤
  • 前頭側頭型認知症治療薬の世界市場2023年：抗うつ剤、抗精神病薬
  • 注意欠陥・多動性症候群治療の世界市場2023年：精神刺激薬、非精神刺激薬
  • 腎皮質壊死治療の世界市場2023年：プレドニゾロン、アスピリン、炭酸水素ナトリウム、N-アセチルシステイン、スタチン、その他
  • 結晶性関節炎治療の世界市場2023年：経口剤、注射剤
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7461 )"子宮内膜症治療薬の世界市場2023年：ホルモン避妊薬、プロゲステロン補充療法、GnRHAアナログ" (英文：Global Endometriosis Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。